Related Experiment Videos
Therapeutic vaccination against HIV: current progress and future possibilities
1National Centre in HIV Epidemiology and Clinical Research (NCHECR), University of New South Wales (UNSW), 376 Victoria Street, Darlinghurst, Sydney, NSW 2010, Australia.
Clinical Science (London, England : 1979)
|December 13, 2005
Summary
Developing a therapeutic vaccine for Human Immunodeficiency Virus (HIV) aims to boost immune responses, potentially reducing reliance on current complex antiretroviral therapy (ART). Challenges remain in achieving efficacy and understanding protective immunity for this viral disease.
Area of Science:
- Immunology
- Virology
- Vaccinology
Background:
- Current antiretroviral therapy (ART) for Human Immunodeficiency Virus (HIV) infection effectively reduces mortality but involves complex, toxic, and expensive drug regimens.
- Existing therapies cannot eradicate latent HIV reservoirs, necessitating lifelong treatment.
- Therapeutic vaccination is explored as a strategy to enhance anti-HIV immune responses, potentially reducing or delaying the need for ART.
Purpose of the Study:
- To review recent progress in the development of therapeutic vaccines for HIV.
- To summarize the challenges hindering the creation of an effective therapeutic HIV vaccine.
- To explore strategies for improving the potency and breadth of anti-HIV immune responses.
Main Methods:
- Review of various therapeutic vaccine approaches, including whole inactivated HIV-1, protein subunits, synthetic peptides, DNA vaccines, and viral vectors.
- Analysis of investigations targeting both cell-mediated and antibody-mediated immunity.
- Examination of research conducted without a complete understanding of HIV pathogenesis or correlates of protective immunity.
Main Results:
- A variety of vaccine candidates have been developed and investigated.
- Despite progress, no licensed therapeutic vaccine currently exists for any viral disease, including HIV.
- Development has proceeded without a clear understanding of disease pathogenesis or protective immunity correlates.
Conclusions:
- Therapeutic vaccination holds promise for improving HIV management by potentially reducing ART reliance.
- Significant challenges persist in developing a licensed and effective therapeutic HIV vaccine.
- Further research is needed to elucidate HIV pathogenesis and identify correlates of protective immunity to guide vaccine development.